Emefcy
Caesarea
About Emefcy
Emefcy, Ltd. develops and manufactures a bio-energy system that produces energy in the form of electricity or hydrogen from wastewater. The company develops MEGAWATTERTM, a wastewater treatment solution based on microbial fuel cell technology that enables direct electricity generation or hydrogen production from wastewater as means for wastewater treatment. Its system directly generates DC electricity by treating wastewater from industrial, agricultural, and municipal sources; performs water and wastewater de-nitrification without polluting the water with organic carbon and bacteria; generates electricity in lagoons and stabilization ponds; and directly produces hydrogen from wastewater. The company's solution is primarily used in pulp and paper, petrochemical processing, food and beverage, and agricultural industries. Emefcy, Ltd. was founded in 2007 and is based in Caesarea, Israel.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $23.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2016)
- Ticker: asx:EMC
- Website: emefcy.com
- Phone: +972 4 627 7555
Industries & Categories
Electronics, Environmental Engineering, Water, Water Purification
Social Profiles
Canonical: https://fsome.com/organization/emefcy-2244584 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.